Compared to NAFLD patients without SDS, those with SDS might have even low levels of ALB due to the pro-inflammatory effects of Rhizopus. Therefore, we hypothesize that the enrichment of pro-inflammatory bacteria and fungi in NAFLD patients with SDS is associated with elevated inflammation levels and impaired immunity. The gene discussed is ALB; the disease is metabolic dysfunction-associated steatotic liver disease.